Thursday, 24 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14475
Articles
Policy / Regulatory
China’s COVID-19 Vaccination Second Booster Shot Plan Released
January 28, 2025
Company
Drug
ImmuneOnco’s IMM2520 Receives FDA Clinical Trial Approval
January 28, 2025
Company
Drug
Jiangsu Recbio’s COVID-19 Vaccine ReCOV Shows Superiority in Phase II Trial
January 28, 2025
Company
Drug
Treadwell Therapeutics Presents PLK4 Inhibitor Data at ASH Annual Meeting
January 28, 2025
Company
Medical Device
Cryofocus Biotechnology’s RDN System Gains FDA Breakthrough Therapy Designation
January 28, 2025
Policy / Regulatory
Beijing Releases COVID-19 Infection Drug List to Address Stocking Issues
January 28, 2025
Company
Deals
Cutia Therapeutic Plans IPO on Hong Kong Stock Exchange
January 28, 2025
Policy / Regulatory
China’s State Council Boosts Internet Medical Services Amid COVID-19
January 28, 2025
Company
Drug
Asieris Pharmaceuticals Enrolls First Patient in Phase II Study for APL-1202
January 28, 2025
Company
Drug
Jiangsu Yahong Administers First Dose of Hexvix in Hainan Pilot Zone
January 28, 2025
Company
Drug
Ascletis Pharma Announces Positive Phase I Results for ASC10 in COVID-19 Treatment
January 28, 2025
Company
Deals
Yantai Dongcheng to Acquire US Firm XingImaging for $30.2M
January 28, 2025
1
2
…
1,075
1,076
1,077
1,078
1,079
…
1,206
1,207
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?